Delivery Order SPE2DB22D3501-SPE2DB24FVB66
Award Date 3/28/24
Potential Completion Date 4/18/24
Potential Value $9.1K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide TEZSPIRE 210 MG/1.91 ML PEN 1.91ML pharmaceutical products. The order has a potential value of $9,061.20 and a completion date of February 28, 2024. Amerisourcebergen Drug Corp is the prime contractor, and the order was placed through DLA's primary indefinite delivery contract with the company, which has a potential value of up...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a for-profit pharmaceutical distribution company, for the supply of TEZSPIRE 210 MG/1.91 ML PEN 1.91ML. The $6,795.87 contract has an ultimate completion date of April 8, 2024. AmerisourceBergen Drug Corp, through its Corporate Office division in Conshohocken, Pennsylvania, is the prime contractor. This award is part of a larger $999,999,999.00...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply 4564097758 TEZSPIRE 210 MG/1.91 ML PEN 1.91ML pharmaceutical products. The contract ceiling value is $4,530.60 and has a period of performance through April 17, 2024. This delivery order is part of Amerisourcebergen Drug Corp's existing indefinite delivery contract with DLA, valued up to $999,999,999.00 through...
- The Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide the pharmaceutical product TEZSPIRE 210 MG/1.91 ML PEN 1.91ML. The $6,795.87 contract has an ultimate completion date of April 26, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract with the DLA, valued up to $999,999,999.00, which serves as the primary...
- The Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of TEZSPIRE 210 MG/1.91 ML PEN 1.91ML. The $4,530.60 firm-fixed-price contract has an ultimate completion date of October 16, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a comprehensive range of medical...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide the pharmaceutical product TEZSPIRE 210 MG/1.91 ML PEN 1.91ML. The contract, valued at $6,795.87, has an ultimate completion date of April 23, 2024. Amerisourcebergen Drug Corp is the prime contractor and has a parent company, Cencora, Inc., which is also doing business as Amerisourcebergen. This delivery order...
- The U.S. Defense Logistics Agency (DLA) awarded a $4,530.60 firm fixed-price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the supply of TEZSPIRE 210 MG/1.91 ML PEN 1.91ML, a pharmaceutical product. The award has an ultimate completion date of May 28, 2024. This contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $9,061.20 to Amerisourcebergen Drug Corp, a for-profit subsidiary of Amerisourcebergen Corporation, for the supply of the pharmaceutical product TEZSPIRE 210 MG/1.91 ML PEN 1.91ML. The contract has a performance period through March 28, 2024. Amerisourcebergen Drug Corp is the prime contractor on this award, which is not designated as a set-aside contract. Amerisourcebergen Drug Corp also holds an...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $6,795.87 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide TEZSPIRE 210 MG/1.91 ML SYRING 1.91ML pharmaceutical products. This delivery order is under a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 awarded solely to Amerisourcebergen Drug Corp, which serves as the primary vehicle for the company to supply pharmaceuticals and...
- The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of TEZSPIRE 210 MG/1.91 ML PEN 1.91ML. The firm-fixed-price contract, valued at $7,030.77, has an ultimate completion date of January 23, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB24FVB66Delivery Order
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide TEZSPIRE 210 MG/1.91 ML PEN 1.91ML pharmaceutical products. The $9,061.20 award has an ultimate completion date of April 18, 2024. Amerisourcebergen Drug Corp is also the prime contractor on an indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. This contract award does not have a set-aside designation.
Generated 6/27/24, 9:46 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.1k | 3/28/24 |